Aoyagi, T., & 		Kuroda, I.
2022 Oct 31.  Castration-Synchronized Upfront Docetaxel for metastatic Hormone Sensitive Prostate Cancer considering Epithelial to Mesenchymal Transition. Medical Research Archives. [Online] 10:10